Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Depression 1.4.3 MS 1.4.4 bipolar disorder 1.4.5 schizophrenia 1.4.6 epilepsy 1.4.7 AD 1.4.8 Parkinson' s 1.4.9 others 1.5 Market by Application 1.5.1 Global Central Nervous System Disorders Therapeutics Market Share by Application (2014-2025) 1.5.2 Clinicals 1.5.3 Hospitials 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Central Nervous System Disorders Therapeutics Market Size 2.2 Central Nervous System Disorders Therapeutics Growth Trends by Regions 2.2.1 Central Nervous System Disorders Therapeutics Market Size by Regions (2014-2025) 2.2.2 Central Nervous System Disorders Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Central Nervous System Disorders Therapeutics Market Size by Manufacturers 3.1.1 Global Central Nervous System Disorders Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Central Nervous System Disorders Therapeutics Key Players Head office and Area Served 3.3 Key Players Central Nervous System Disorders Therapeutics Product/Solution/Service 3.4 Date of Enter into Central Nervous System Disorders Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) 4.2 Global Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Central Nervous System Disorders Therapeutics Market Size (2014-2019) 5.2 Central Nervous System Disorders Therapeutics Key Players in United States 5.3 United States Central Nervous System Disorders Therapeutics Market Size by Type 5.4 United States Central Nervous System Disorders Therapeutics Market Size by Application 6 Europe 6.1 Europe Central Nervous System Disorders Therapeutics Market Size (2014-2019) 6.2 Central Nervous System Disorders Therapeutics Key Players in Europe 6.3 Europe Central Nervous System Disorders Therapeutics Market Size by Type 6.4 Europe Central Nervous System Disorders Therapeutics Market Size by Application 7 China 7.1 China Central Nervous System Disorders Therapeutics Market Size (2014-2019) 7.2 Central Nervous System Disorders Therapeutics Key Players in China 7.3 China Central Nervous System Disorders Therapeutics Market Size by Type 7.4 China Central Nervous System Disorders Therapeutics Market Size by Application 8 Japan 8.1 Japan Central Nervous System Disorders Therapeutics Market Size (2014-2019) 8.2 Central Nervous System Disorders Therapeutics Key Players in Japan 8.3 Japan Central Nervous System Disorders Therapeutics Market Size by Type 8.4 Japan Central Nervous System Disorders Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Central Nervous System Disorders Therapeutics Market Size (2014-2019) 9.2 Central Nervous System Disorders Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Type 9.4 Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Application 10 India 10.1 India Central Nervous System Disorders Therapeutics Market Size (2014-2019) 10.2 Central Nervous System Disorders Therapeutics Key Players in India 10.3 India Central Nervous System Disorders Therapeutics Market Size by Type 10.4 India Central Nervous System Disorders Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Central Nervous System Disorders Therapeutics Market Size (2014-2019) 11.2 Central Nervous System Disorders Therapeutics Key Players in Central & South America 11.3 Central & South America Central Nervous System Disorders Therapeutics Market Size by Type 11.4 Central & South America Central Nervous System Disorders Therapeutics Market Size by Application 12 International Players Profiles 12.1 Eli Lilly 12.1.1 Eli Lilly Company Details 12.1.2 Company Description and Business Overview 12.1.3 Central Nervous System Disorders Therapeutics Introduction 12.1.4 Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) 12.1.5 Eli Lilly Recent Development 12.2 GlaxoSmithKline 12.2.1 GlaxoSmithKline Company Details 12.2.2 Company Description and Business Overview 12.2.3 Central Nervous System Disorders Therapeutics Introduction 12.2.4 GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) 12.2.5 GlaxoSmithKline Recent Development 12.3 Janssen Pharmaceuticals 12.3.1 Janssen Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 Central Nervous System Disorders Therapeutics Introduction 12.3.4 Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) 12.3.5 Janssen Pharmaceuticals Recent Development 12.4 Novartis 12.4.1 Novartis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Central Nervous System Disorders Therapeutics Introduction 12.4.4 Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) 12.4.5 Novartis Recent Development 12.5 Pfizer 12.5.1 Pfizer Company Details 12.5.2 Company Description and Business Overview 12.5.3 Central Nervous System Disorders Therapeutics Introduction 12.5.4 Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) 12.5.5 Pfizer Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Central Nervous System Disorders Therapeutics Key Market Segments Table Key Players Central Nervous System Disorders Therapeutics Covered Table Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Central Nervous System Disorders Therapeutics Market Size Market Share by Type 2014-2025 Figure Depression Figures Table Key Players of Depression Figure MS Figures Table Key Players of MS Figure bipolar disorder Figures Table Key Players of bipolar disorder Figure schizophrenia Figures Table Key Players of schizophrenia Figure epilepsy Figures Table Key Players of epilepsy Figure AD Figures Table Key Players of AD Figure Parkinson' s Figures Table Key Players of Parkinson' s Figure others Figures Table Key Players of others Table Global Central Nervous System Disorders Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Clinicals Case Studies Figure Hospitials Case Studies Figure Central Nervous System Disorders Therapeutics Report Years Considered Table Global Central Nervous System Disorders Therapeutics Market Size 2014-2025 (Million US$) Figure Global Central Nervous System Disorders Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Share by Regions 2014-2019 Figure Global Central Nervous System Disorders Therapeutics Market Share by Regions 2014-2019 Figure Global Central Nervous System Disorders Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Central Nervous System Disorders Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Central Nervous System Disorders Therapeutics Market Share by Manufacturers in 2018 Table Global Central Nervous System Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Central Nervous System Disorders Therapeutics Product/Solution/Service Table Date of Enter into Central Nervous System Disorders Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Size Share by Type (2014-2019) Figure Global Central Nervous System Disorders Therapeutics Market Size Market Share by Type (2014-2019) Table Global Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Central Nervous System Disorders Therapeutics Market Size Share by Application (2014-2019) Figure Global Central Nervous System Disorders Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Central Nervous System Disorders Therapeutics Revenue Market Share by Application in 2018 Figure United States Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table United States Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table United States Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Figure Europe Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table Europe Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table Europe Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Figure China Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table China Central Nervous System Disorders Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table China Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Figure Japan Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table Japan Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table Japan Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Figure India Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table India Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table India Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Figure Central & South America Central Nervous System Disorders Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Central Nervous System Disorders Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Central Nervous System Disorders Therapeutics Market Share (2018-2019) Table Central & South America Central Nervous System Disorders Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Central Nervous System Disorders Therapeutics Market Share by Type (2014-2019) Table Central & South America Central Nervous System Disorders Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Central Nervous System Disorders Therapeutics Market Share by Application (2014-2019) Table Eli Lilly Company Details Table Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019) (Million US$) Figure Eli Lilly Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019) Table Eli Lilly Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019) Table GlaxoSmithKline Recent Development Table Janssen Pharmaceuticals Company Details Table Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$) Figure Janssen Pharmaceuticals Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019) Table Janssen Pharmaceuticals Recent Development Table Novartis Company Details Table Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2014-2019) Table Pfizer Recent Development Table Global Central Nervous System Disorders Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Central Nervous System Disorders Therapeutics Market Size Share by Regions (2019-2025) Figure Global Central Nervous System Disorders Therapeutics Market Size Share by Regions in 2025 Figure United States Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Central Nervous System Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Central Nervous System Disorders Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Central Nervous System Disorders Therapeutics Market Size by Product (2019-2025) Figure Global Central Nervous System Disorders Therapeutics Market Size by Product in 2025 Table Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Central Nervous System Disorders Therapeutics Market Size by Application (2019-2025) Figure Global Central Nervous System Disorders Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Eli Lilly GlaxoSmithKline Janssen Pharmaceuticals Novartis Pfizer